![Michael Baran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Baran
Directeur/Membre du Conseil chez
Imcheck Therapeutics SAS
Profil
Michael Baran, MBA, PHD is Executive Director, WRDM and Partner at Pfizer Ventures.
Mike is responsible for identifying, evaluating, making and managing equity investments aligned with the future directions of Pfizer.
He currently has responsibility for Pfizer’s investments in Anjarium Biosciences, Autobahn Therapeutics, Interius BioTherapeutics, ImCheck Therapeutics, ImmunOs Therapeutics, Magnolia Neurosciences, Mediar Therapeutics, Parthenon Therapeutics, and TRex Bio.
His prior investment responsibilities include Accelerator Life Science Partners, Bluelight Therapeutics, AnTolRx, and Netvation DL.
Mike is an Adjunct Assistant Professor in the Department of Biomedical Engineering at Stony Brook University and plays an active role in the NY/NJ early life science ecosystem as a Mentor in Residence for Rutgers University and a Venture Advisor for eLabNYC.
Prior to his current role, Mike held responsibilities in R&D portfolio strategy as well as managing scientific affairs for the R&D President’s office at Pfizer.
Mike joined Pfizer from Nexomics Biosciences, a structural biology biotech company which he co-founded in 2006.
Prior to his involvement at Nexomics he worked within the NIH Protein Structure Initiative’s Northeast Structural Genomics Consortium coordinating protein structure production efforts, including bioinformatics, protein expression/purification and 3D protein structure determination.
Mike received his BA in Biochemistry from Syracuse University, holds a MBA from Rutgers Business School, and a PhD in Biochemistry from Robert Wood Johnson Medical School / Rutgers, the State University of New Jersey.
Postes actifs de Michael Baran
| Sociétés | Poste | Début |
|---|---|---|
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Private Equity Investor | 01/09/2018 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Directeur/Membre du Conseil | 04/12/2019 |
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Directeur/Membre du Conseil | - |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Engages in research and development of drugs | Directeur/Membre du Conseil | 01/04/2020 |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Directeur/Membre du Conseil | 01/01/2021 |
Trex Bio, Inc.
 Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Directeur/Membre du Conseil | 01/11/2021 |
Entrepreneurship Lab NYC
 Entrepreneurship Lab NYC Miscellaneous Commercial ServicesCommercial Services Engages in organizing entrepreneurship education and networking program | Consultant / Advisor | 01/01/2016 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Directeur/Membre du Conseil | 01/06/2022 |
Anciens postes connus de Michael Baran
| Sociétés | Poste | Fin |
|---|---|---|
BlueLight Therapeutics, Inc.
 BlueLight Therapeutics, Inc. BiotechnologyHealth Technology Develops novel systems to analyze real-time protein function for research and clinical applications | Directeur/Membre du Conseil | 01/10/2021 |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Baran
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
BlueLight Therapeutics, Inc.
BlueLight Therapeutics, Inc. BiotechnologyHealth Technology Develops novel systems to analyze real-time protein function for research and clinical applications | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Venture Investments LLC
Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Finance |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Magnolia Neurosciences Corp.
Magnolia Neurosciences Corp. BiotechnologyHealth Technology Engages in research and development of drugs | Health Technology |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Health Technology |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Health Technology |
Trex Bio, Inc.
Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Entrepreneurship Lab NYC
Entrepreneurship Lab NYC Miscellaneous Commercial ServicesCommercial Services Engages in organizing entrepreneurship education and networking program | Commercial Services |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
